CA2843941A1 - Method of fabricating modifiable occlusion device - Google Patents
Method of fabricating modifiable occlusion device Download PDFInfo
- Publication number
- CA2843941A1 CA2843941A1 CA2843941A CA2843941A CA2843941A1 CA 2843941 A1 CA2843941 A1 CA 2843941A1 CA 2843941 A CA2843941 A CA 2843941A CA 2843941 A CA2843941 A CA 2843941A CA 2843941 A1 CA2843941 A1 CA 2843941A1
- Authority
- CA
- Canada
- Prior art keywords
- frangible material
- spray
- vessel
- aneurysm
- selecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 60
- 206010002329 Aneurysm Diseases 0.000 claims abstract description 55
- 239000007921 spray Substances 0.000 claims abstract description 50
- 229920000642 polymer Polymers 0.000 claims abstract description 20
- 239000002904 solvent Substances 0.000 claims abstract description 17
- 239000000758 substrate Substances 0.000 claims abstract description 16
- 239000007788 liquid Substances 0.000 claims abstract description 14
- 229920000249 biocompatible polymer Polymers 0.000 claims abstract description 10
- 238000013519 translation Methods 0.000 claims abstract description 7
- 238000012276 Endovascular treatment Methods 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 38
- 238000002513 implantation Methods 0.000 claims description 11
- 239000012528 membrane Substances 0.000 claims description 10
- 229920001610 polycaprolactone Polymers 0.000 claims description 10
- 239000004632 polycaprolactone Substances 0.000 claims description 10
- 230000001154 acute effect Effects 0.000 claims description 9
- 230000003628 erosive effect Effects 0.000 claims description 8
- 208000028867 ischemia Diseases 0.000 claims description 8
- 230000004888 barrier function Effects 0.000 claims description 7
- 210000005166 vasculature Anatomy 0.000 claims description 6
- 238000003780 insertion Methods 0.000 claims description 4
- 230000037431 insertion Effects 0.000 claims description 4
- 229920002635 polyurethane Polymers 0.000 claims description 4
- 239000004814 polyurethane Substances 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 229920002988 biodegradable polymer Polymers 0.000 claims 2
- 239000004621 biodegradable polymer Substances 0.000 claims 2
- 239000000835 fiber Substances 0.000 description 25
- 238000010276 construction Methods 0.000 description 17
- 239000012530 fluid Substances 0.000 description 12
- 239000011148 porous material Substances 0.000 description 10
- 210000001367 artery Anatomy 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 102000004882 Lipase Human genes 0.000 description 7
- 108090001060 Lipase Proteins 0.000 description 7
- 239000004367 Lipase Substances 0.000 description 7
- 230000003073 embolic effect Effects 0.000 description 7
- 235000019421 lipase Nutrition 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 238000005191 phase separation Methods 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000001000 micrograph Methods 0.000 description 4
- 230000000149 penetrating effect Effects 0.000 description 4
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 3
- 238000001523 electrospinning Methods 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000002085 persistent effect Effects 0.000 description 3
- 239000004633 polyglycolic acid Substances 0.000 description 3
- 229950008885 polyglycolic acid Drugs 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000001732 thrombotic effect Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 239000002033 PVDF binder Substances 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 210000001841 basilar artery Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 239000013590 bulk material Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000002631 hypothermal effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 208000022211 Arteriovenous Malformations Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010053648 Vascular occlusion Diseases 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008321 arterial blood flow Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000005744 arteriovenous malformation Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000012888 cubic function Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012148 non-surgical treatment Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 208000021331 vascular occlusion disease Diseases 0.000 description 1
- 201000009371 venous hemangioma Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/1214—Coils or wires
- A61B17/1215—Coils or wires comprising additional materials, e.g. thrombogenic, having filaments, having fibers, being coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/03—Automatic limiting or abutting means, e.g. for safety
- A61B2090/037—Automatic limiting or abutting means, e.g. for safety with a frangible part, e.g. by reduced diameter
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Surgical Instruments (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/796,415 | 2013-03-12 | ||
| US13/796,415 US20130190805A1 (en) | 2011-03-31 | 2013-03-12 | Method of fabricating modifiable occlusion device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2843941A1 true CA2843941A1 (en) | 2014-09-12 |
Family
ID=50276939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2843941A Abandoned CA2843941A1 (en) | 2013-03-12 | 2014-02-26 | Method of fabricating modifiable occlusion device |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2777543B1 (enExample) |
| JP (1) | JP6373608B2 (enExample) |
| KR (1) | KR102273599B1 (enExample) |
| CN (1) | CN104068905B (enExample) |
| AU (1) | AU2014201043B2 (enExample) |
| BR (1) | BR102014005731A2 (enExample) |
| CA (1) | CA2843941A1 (enExample) |
| DK (1) | DK2777543T3 (enExample) |
| IN (1) | IN2014DE00464A (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11357486B2 (en) | 2009-12-30 | 2022-06-14 | Vivasure Medical Limited | Closure system and uses thereof |
| IN2014DE00518A (enExample) * | 2013-03-13 | 2015-06-12 | Depuy Synthes Products Llc | |
| EP3232939B1 (en) * | 2014-12-15 | 2020-09-23 | Vivasure Medical Limited | Implantable sealable member with mesh layer |
| WO2016096932A1 (en) | 2014-12-15 | 2016-06-23 | Vivasure Medical Limited | Closure apparatus with flexible sealable member and flexible support member |
| US10524952B2 (en) * | 2015-06-05 | 2020-01-07 | Sano V Pte Ltd | Devices and methods for pressure-responsive reshaping of blood vessels |
| US11311280B2 (en) | 2015-12-15 | 2022-04-26 | Vivasure Medical Limited | Arteriotomy closure apparatus with slotted shoe for advantageous pressure distribution |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US692631A (en) | 1899-10-06 | 1902-02-04 | Charles S Farquhar | Apparatus for electrically dispersing fluids. |
| US705691A (en) | 1900-02-20 | 1902-07-29 | William James Morton | Method of dispersing fluids. |
| US1975504A (en) | 1929-12-07 | 1934-10-02 | Richard Schreiber Gastell | Process and apparatus for preparing artificial threads |
| US2048651A (en) * | 1933-06-23 | 1936-07-21 | Massachusetts Inst Technology | Method of and apparatus for producing fibrous or filamentary material |
| US2349950A (en) | 1937-08-18 | 1944-05-30 | Formhals Anton | Method and apparatus for spinning |
| US5229045A (en) * | 1991-09-18 | 1993-07-20 | Kontron Instruments Inc. | Process for making porous membranes |
| US5938697A (en) * | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
| US6187036B1 (en) | 1998-12-11 | 2001-02-13 | Endologix, Inc. | Endoluminal vascular prosthesis |
| US7270675B2 (en) * | 2002-05-10 | 2007-09-18 | Cordis Corporation | Method of forming a tubular membrane on a structural frame |
| US7335265B1 (en) | 2002-10-08 | 2008-02-26 | Advanced Cardiovascular Systems Inc. | Apparatus and method for coating stents |
| EP1431019B1 (en) * | 2002-12-17 | 2007-03-07 | Integrated Biomaterial & Cell Technologies S.R.L. | Apparatus and its use for producing porous membranes for medical use |
| US7763011B2 (en) * | 2003-12-22 | 2010-07-27 | Boston Scientific Scimed, Inc. | Variable density braid stent |
| US7156871B2 (en) | 2004-10-28 | 2007-01-02 | Cordis Neurovascular, Inc. | Expandable stent having a stabilized portion |
| WO2007117645A2 (en) | 2006-04-07 | 2007-10-18 | Penumbra, Inc. | Aneurysm occlusion system and method |
| WO2008076383A2 (en) | 2006-12-18 | 2008-06-26 | Med Institute Inc. | Stent graft with releasable therapeutic agent |
| US20100274276A1 (en) * | 2009-04-22 | 2010-10-28 | Ricky Chow | Aneurysm treatment system, device and method |
| WO2011133183A1 (en) * | 2010-04-20 | 2011-10-27 | University Of Utah Research Foundation | Phase separation sprayed scaffold |
| US8535590B2 (en) * | 2011-01-12 | 2013-09-17 | Cook Medical Technologies Llc | Spray system and method of making phase separated polymer membrane structures |
| US20120253377A1 (en) * | 2011-03-31 | 2012-10-04 | Codman & Shurtleff, Inc. | Modifiable occlusion device |
-
2014
- 2014-02-18 IN IN464DE2014 patent/IN2014DE00464A/en unknown
- 2014-02-26 CA CA2843941A patent/CA2843941A1/en not_active Abandoned
- 2014-02-27 AU AU2014201043A patent/AU2014201043B2/en not_active Ceased
- 2014-03-07 KR KR1020140026863A patent/KR102273599B1/ko active Active
- 2014-03-11 JP JP2014047330A patent/JP6373608B2/ja active Active
- 2014-03-11 DK DK14158741.0T patent/DK2777543T3/da active
- 2014-03-11 EP EP14158741.0A patent/EP2777543B1/en active Active
- 2014-03-12 CN CN201410088950.4A patent/CN104068905B/zh active Active
- 2014-03-12 BR BRBR102014005731-5A patent/BR102014005731A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK2777543T3 (da) | 2018-01-29 |
| IN2014DE00464A (enExample) | 2015-06-12 |
| CN104068905A (zh) | 2014-10-01 |
| AU2014201043A1 (en) | 2014-10-02 |
| BR102014005731A2 (pt) | 2015-01-06 |
| JP6373608B2 (ja) | 2018-08-15 |
| EP2777543B1 (en) | 2017-11-29 |
| AU2014201043B2 (en) | 2018-11-08 |
| KR20140111963A (ko) | 2014-09-22 |
| CN104068905B (zh) | 2018-07-03 |
| KR102273599B1 (ko) | 2021-07-07 |
| EP2777543A1 (en) | 2014-09-17 |
| JP2014171899A (ja) | 2014-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2773163C (en) | Modifiable occlusion device | |
| AU2014201043B2 (en) | Method of fabricating modifiable occlusion device | |
| US20130204288A1 (en) | Modifiable occlusion device | |
| JP6657281B2 (ja) | 改善された変化可能な閉塞装置 | |
| US20080097495A1 (en) | Thin Film Metallic Device for Plugging Aneurysms or Vessels | |
| JP2013539398A (ja) | 血管の開孔又は窪みを閉じるためのデバイス | |
| AU2016374360B2 (en) | Implant | |
| CN116568242A (zh) | 用于治疗动脉瘤的医用植入物 | |
| US20130190805A1 (en) | Method of fabricating modifiable occlusion device | |
| US20230263528A1 (en) | Intrasacular flow diverter and related methods | |
| JP2019505347A (ja) | ステント留置術用繊維管状導管 | |
| EP2575678B1 (en) | Device for placement in a hollow organ, in particular for holding open said hollow organ and method for producing such device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20190225 |
|
| FZDE | Discontinued |
Effective date: 20220823 |
|
| FZDE | Discontinued |
Effective date: 20220823 |